$AVEO News Article - AVEO Oncology Announces Collaboration with Bristol Myers Squibb to Evaluate FOTIVDA (tivozanib) in Combination with OPDIVO (nivolumab) in Pivotal Phase 3 TiNivo-2 Trial in IO Relapsed Renal Cell Carcinoma
https://marketwirenews.com/news-releases/aveo...61827.html